136 related articles for article (PubMed ID: 37081263)
1. Identification and evaluation of thermotolerance of yeasts from milk in natura exposed to high temperature and slow and fast pasteurization.
da Silva Campos J; Júnior ACV; Boniek D; da Silva DL; de Paula Lana UG; Fernandes JV; de Resende Stoianoff MA; Andrade VS
Braz J Microbiol; 2023 Jun; 54(2):1075-1082. PubMed ID: 37081263
[TBL] [Abstract][Full Text] [Related]
2. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
3. Distribution of Pathogenic Yeasts in Different Clinical Samples: Their Identification, Antifungal Susceptibility Pattern, and Cell Invasion Assays.
Pote ST; Sonawane MS; Rahi P; Shah SR; Shouche YS; Patole MS; Thakar MR; Sharma R
Infect Drug Resist; 2020; 13():1133-1145. PubMed ID: 32368104
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology and Antifungal Susceptibility of
Badiee P; Boekhout T; Haddadi P; Mohammadi R; Ghadimi-Moghadam A; Soltani J; Zarei Mahmoudabadi A; Ayatollahi Mousavi SA; Najafzadeh MJ; Diba K; Salimi-Khorashad AR; Amin Shahidi M; Ghasemi F; Jafarian H
Microbiol Spectr; 2022 Dec; 10(6):e0245322. PubMed ID: 36445122
[TBL] [Abstract][Full Text] [Related]
5. Antifungal susceptibility of non-albicans
Namvar Z; Sepahy AA; Tabatabaei RR; Rezaie S
Iran J Microbiol; 2019 Dec; 11(6):520-526. PubMed ID: 32148684
[TBL] [Abstract][Full Text] [Related]
6. Echinocandin and triazole antifungal susceptibility profiles for clinical opportunistic yeast and mold isolates collected from 2010 to 2011: application of new CLSI clinical breakpoints and epidemiological cutoff values for characterization of geographic and temporal trends of antifungal resistance.
Pfaller MA; Messer SA; Woosley LN; Jones RN; Castanheira M
J Clin Microbiol; 2013 Aug; 51(8):2571-81. PubMed ID: 23720791
[TBL] [Abstract][Full Text] [Related]
7. Antifungal susceptibility profiles of bloodstream yeast isolates by Sensititre YeastOne over nine years at a large Italian teaching hospital.
Posteraro B; Spanu T; Fiori B; De Maio F; De Carolis E; Giaquinto A; Prete V; De Angelis G; Torelli R; D'Inzeo T; Vella A; De Luca A; Tumbarello M; Ricciardi W; Sanguinetti M
Antimicrob Agents Chemother; 2015 Jul; 59(7):3944-55. PubMed ID: 25896705
[TBL] [Abstract][Full Text] [Related]
8. Identification of uncommon oral yeasts from cancer patients by MALDI-TOF mass spectrometry.
Aslani N; Janbabaei G; Abastabar M; Meis JF; Babaeian M; Khodavaisy S; Boekhout T; Badali H
BMC Infect Dis; 2018 Jan; 18(1):24. PubMed ID: 29310582
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of a Commercial Multiplex Tandem Polymerase Chain Reaction Method for the Identification of the Yeasts Isolated from Blood Cultures].
Er H; Koyuncu Özyurt Ö; Özhak B; Yazısız H; Öngüt G; Eres Sarıtaş Z; Dönmez L; Çolak D; Günseren F; Öğünç D
Mikrobiyol Bul; 2020 Oct; 54(4):596-605. PubMed ID: 33107288
[TBL] [Abstract][Full Text] [Related]
10. Isolation of antifungal-resistant yeasts from bulk milk in Japan.
Miyake R; Ito T; Kamata H; Kano R
J Vet Med Sci; 2021 Jul; 83(7):1090-1092. PubMed ID: 34108335
[TBL] [Abstract][Full Text] [Related]
11. Antifungal susceptibility of 262 bloodstream yeast isolates from a mixed cancer and non-cancer patient population: is there a correlation between in-vitro resistance to fluconazole and the outcome of fungemia?
Kovacicova G; Krupova Y; Lovaszova M; Roidova A; Trupl J; Liskova A; Hanzen J; Milosovic P; Lamosova M; Macekova L; Szovenyiova Z; Purgelova A; Obertik T; Bille J; Krcmery V
J Infect Chemother; 2000 Dec; 6(4):216-21. PubMed ID: 11810569
[TBL] [Abstract][Full Text] [Related]
12. Candida infanticola and Candida spencermartinsiae yeasts: Possible emerging species in cancer patients.
Shokohi T; Aslani N; Ahangarkani F; Meyabadi MF; Hagen F; Meis JF; Boekhout T; Kolecka A; Badali H
Microb Pathog; 2018 Feb; 115():353-357. PubMed ID: 29292174
[TBL] [Abstract][Full Text] [Related]
13. Detection of Candida species resistant to azoles in the microbiota of rheas (Rhea americana): possible implications for human and animal health.
Brilhante RSN; de Alencar LP; Cordeiro RA; Castelo-Branco DSCM; Teixeira CEC; Macedo RB; Lima DT; Paiva MAN; Monteiro AJ; Alves ND; Franco de Oliveira M; Sidrim JJC; Rocha MFG; Bandeira TJPG; Rodrigues TJS
J Med Microbiol; 2013 Jun; 62(Pt 6):889-895. PubMed ID: 23493027
[TBL] [Abstract][Full Text] [Related]
14. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance.
Krcmery V; Barnes AJ
J Hosp Infect; 2002 Apr; 50(4):243-60. PubMed ID: 12014897
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology of candidemia in Shiraz, southern Iran: A prospective multicenter study (2016-2018).
Arastehfar A; Yazdanpanah S; Bakhtiari M; Fang W; Pan W; Mahmoudi S; Pakshir K; Daneshnia F; Boekhout T; Ilkit M; Perlin DS; Zomorodian K; Zand F
Med Mycol; 2021 May; 59(5):422-430. PubMed ID: 32692816
[TBL] [Abstract][Full Text] [Related]
16. Analysis of global antifungal surveillance results reveals predominance of Erg11 Y132F alteration among azole-resistant Candida parapsilosis and Candida tropicalis and country-specific isolate dissemination.
Castanheira M; Deshpande LM; Messer SA; Rhomberg PR; Pfaller MA
Int J Antimicrob Agents; 2020 Jan; 55(1):105799. PubMed ID: 31520783
[TBL] [Abstract][Full Text] [Related]
17. Diversity and antifungal susceptibility of yeasts from tropical freshwater environments in Southeastern Brazil.
Medeiros AO; Kohler LM; Hamdan JS; Missagia BS; Barbosa FA; Rosa CA
Water Res; 2008 Aug; 42(14):3921-9. PubMed ID: 18678387
[TBL] [Abstract][Full Text] [Related]
18. Isavuconazole, micafungin, and 8 comparator antifungal agents' susceptibility profiles for common and uncommon opportunistic fungi collected in 2013: temporal analysis of antifungal drug resistance using CLSI species-specific clinical breakpoints and proposed epidemiological cutoff values.
Pfaller MA; Rhomberg PR; Messer SA; Jones RN; Castanheira M
Diagn Microbiol Infect Dis; 2015 Aug; 82(4):303-13. PubMed ID: 25986029
[TBL] [Abstract][Full Text] [Related]
19. Species Diversity and Antifungal Susceptibilities of Oral Yeasts from Patients with Head and Neck Cancer.
Wu J; Gan C; Li J; Liu Y; Chen Z; Zhang Y; Yi G; Sui J; Xu J
Infect Drug Resist; 2021; 14():2279-2288. PubMed ID: 34168468
[TBL] [Abstract][Full Text] [Related]
20. Identification and antifungal susceptibility of a large collection of yeast strains isolated in Tunisian hospitals.
Eddouzi J; Lohberger A; Vogne C; Manai M; Sanglard D
Med Mycol; 2013 Oct; 51(7):737-46. PubMed ID: 23768242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
